Global biopharmaceutical leader Novo Nordisk recently completed the first trial run of its modernized warehousing and logistics center in the Pudong Airport Comprehensive Bonded Zone, successfully importing a batch of diabetes treatment drugs from Denmark. This marks a new milestone for multinational pharmaceutical companies in establishing modern supply chains in China.

Novo Nordisk, founded in 1923 and headquartered in Copenhagen, Denmark, is a global pioneer in biopharmaceuticals. The trial run validated key aspects such as customs clearance efficiency, cold chain management, and digital system integration.

The warehousing and logistics center will cover a wide range of diabetes and obesity treatment products.

Novo Nordisk establishes a modernized warehousing and logistics center in the Pudong Airport Comprehensive Bonded Zone. [Photo/WeChat ID: waigaoqiaowindows]

The Pudong Airport Comprehensive Bonded Zone has provided strong support through institutional innovation, policy support, and technological advancements, creating a "three-engine driven" comprehensive service system. This system offers efficient and transparent supply chain solutions for multinational pharmaceutical enterprises, enhancing the resilience of cross-border supply chains.

The zone has convinced global biopharmaceutical leaders like Novo Nordisk and BD Medical to expand their presence. With its strategic location and advanced infrastructure, Pudong New Area in Shanghai is set to become a central platform for multinational enterprises to connect globally and allocate resources, further strengthening its position in the global pharmaceutical industry.